+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 25Years - 50Years
All Genders
ID06425640

INTERPLAY WITHIN THE DAY Optimizing Intra-day Glucose Control by Intervening on the Day-to-day 24-hour Movement Behavior Patterns in Adults With Type 1 Diabetes Mellitus

Led by University Hospital, Ghent · Updated on 2024-06-06

150

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University Hospital, Ghent

Lead Sponsor

U

University Ghent

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to understand how daily movement patterns affect glucose control in adults aged 25 to 50 with type 1 diabetes mellitus T1DM. Despite the use of continuous glucose monitors, managing blood sugar levels remains challenging, and this study focuses on the combined impact of physical activity, sedentary behavior, and sleep on glucose stability and cardiometabolic health markers. Participants will wear an Actigraph accelerometer for 14 consecutive days to track their 24-hour movement behaviors. Alongside, they will use their own continuous glucose monitor to provide daily glucose data. Additional information will be collected through an online questionnaire, a food diary, and a single visit to a study center for measurements such as blood pressure, weight, and waist and hip circumference. During the study, researchers will evaluate glucose control through measures like time in range and coefficient of variation, as well as cardiometabolic health markers including blood pressure and cholesterol levels. The study is observational and will gather data over approximately one year to inform future interventions that support healthy daily movement behaviors in adults with T1DM.

CONDITIONS

Brief Title

24-hour Movement Behaviors in Adults With Type 1 Diabetes

Who Can Participate

Age: 25Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults between 25 and 50 years
  • Diagnosed with type 1 diabetes mellitus for at least two years
  • Using a continuous glucose monitor
  • Taking a minimum of 10 units of insulin daily
  • Recent HbA1c levels between 6% and 9.5%
Not Eligible

You will not qualify if you...

  • Using a hybrid closed loop insulin pump
  • Shift workers
  • Known cardiovascular diseases affecting walking or heart function
  • Physical disabilities impacting daily activities
  • Conditions affecting normal movement behavior such as advanced diabetic nephropathy, severe lung diseases, or active cancer treatment
  • Visual impairments like significant retinopathy causing vision loss
  • Hypoglycemia unawareness
  • Symptomatic peripheral neuropathy
  • Professional or semi-professional top athletes
  • Participation in another supervised lifestyle or drug intervention

Research Team

L

Lotte Bogaert, PhD

M

Marieke De Craemer, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here